SUMMARY
This is a trial of NAD+ infusions in patients with many different disease processes. Studies in 2018 and 2021 showed that NAD+ infusion allows cells to have more ATP. NAD+ is one of the rate-limiting factors in the conversion of ADP to ATP. By infusing NAD+, the patient has an increased amount of ATP. The code to repair cells and repair DNA damage, cancer, diabetes, aging, many other disease processes is already in our DNA. By providing additional ATP, the cell is able to regenerate itself. This is the theory behind IV-medical.com.
-Kalki Bommaraju, MD, MPH 3/1/2026